C-reaktivt protein, risiko for og overlevelse efter cancer--sekundærpublikation

Kristine H Allin; Stig E Bojesen; Børge G Nordestgaard

C-reaktivt protein, risiko for og overlevelse efter cancer--sekundærpublikation

Kristine H Allin, Stig E Bojesen, Børge G Nordestgaard

2 Citationer (Scopus)

Abstract

10,408 individuals from the general Danish population who had CRP measured at baseline were followed for up to 16 years; 1,624 developed cancer and among these, 998 died during follow-up. Multifactorially adjusted hazard ratios for the highest versus the lowest quintile of CRP were 1.3 (95% confidence interval, 1.0-1.6) for cancer of any type, 2.1 (1.2-3.8) for lung cancer, 1.7 (0.8-3.2) for colorectal cancer, and 0.9 (0.5-1.7) for breast cancer. Multifactorially adjusted hazard ratios for early death in patients with cancer were 1.8 (1.2-2.7) for CRP > 3 versus < 1 mg/L.
Udgivelsesdato: 2009-Nov-23

Bidragets oversatte titel	C-reactive protein, risk of and survival after cancer--secondary publication
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	171
Udgave nummer	48
Sider (fra-til)	3510-3
Antal sider	3
Status	Udgivet - 2009

Citationsformater

@article{fd4bdd402a9711df91b0000ea68e967b,

title = "C-reaktivt protein, risiko for og overlevelse efter cancer--sekund{\ae}rpublikation",

abstract = "10,408 individuals from the general Danish population who had CRP measured at baseline were followed for up to 16 years; 1,624 developed cancer and among these, 998 died during follow-up. Multifactorially adjusted hazard ratios for the highest versus the lowest quintile of CRP were 1.3 (95% confidence interval, 1.0-1.6) for cancer of any type, 2.1 (1.2-3.8) for lung cancer, 1.7 (0.8-3.2) for colorectal cancer, and 0.9 (0.5-1.7) for breast cancer. Multifactorially adjusted hazard ratios for early death in patients with cancer were 1.8 (1.2-2.7) for CRP > 3 versus < 1 mg/L. Udgivelsesdato: 2009-Nov-23",

author = "Allin, {Kristine H} and Bojesen, {Stig E} and Nordestgaard, {B{\o}rge G}",

note = "Keywords: C-Reactive Protein; Cohort Studies; Colorectal Neoplasms; Denmark; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasms; Prospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Tumor Markers, Biological",

year = "2009",

language = "Dansk",

volume = "171",

pages = "3510--3",

journal = "Ugeskrift for Laeger",

issn = "1399-4174",

publisher = "Almindelige Danske Laegeforening",

number = "48",

}

TY - JOUR

T1 - C-reaktivt protein, risiko for og overlevelse efter cancer--sekundærpublikation

AU - Allin, Kristine H

AU - Bojesen, Stig E

AU - Nordestgaard, Børge G

N1 - Keywords: C-Reactive Protein; Cohort Studies; Colorectal Neoplasms; Denmark; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasms; Prospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Tumor Markers, Biological

PY - 2009

Y1 - 2009

N2 - 10,408 individuals from the general Danish population who had CRP measured at baseline were followed for up to 16 years; 1,624 developed cancer and among these, 998 died during follow-up. Multifactorially adjusted hazard ratios for the highest versus the lowest quintile of CRP were 1.3 (95% confidence interval, 1.0-1.6) for cancer of any type, 2.1 (1.2-3.8) for lung cancer, 1.7 (0.8-3.2) for colorectal cancer, and 0.9 (0.5-1.7) for breast cancer. Multifactorially adjusted hazard ratios for early death in patients with cancer were 1.8 (1.2-2.7) for CRP > 3 versus < 1 mg/L. Udgivelsesdato: 2009-Nov-23

AB - 10,408 individuals from the general Danish population who had CRP measured at baseline were followed for up to 16 years; 1,624 developed cancer and among these, 998 died during follow-up. Multifactorially adjusted hazard ratios for the highest versus the lowest quintile of CRP were 1.3 (95% confidence interval, 1.0-1.6) for cancer of any type, 2.1 (1.2-3.8) for lung cancer, 1.7 (0.8-3.2) for colorectal cancer, and 0.9 (0.5-1.7) for breast cancer. Multifactorially adjusted hazard ratios for early death in patients with cancer were 1.8 (1.2-2.7) for CRP > 3 versus < 1 mg/L. Udgivelsesdato: 2009-Nov-23

M3 - Tidsskriftartikel

C2 - 19953727

SN - 1399-4174

VL - 171

SP - 3510

EP - 3513

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 48

ER -